muramidase/leukemia

Lyen an sove nan clipboard la

AtikEsè klinikPatant

Chwazi kalite sòt

Paj 1 soti nan 51 rezilta yo

Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Purified human lysozyme (muramidase) stimulated potassium excretion by the isolated perfused rat kidney. Lysozyme is filtered and reabsorbed, without a tubular maximum. Over 90% of lysozyme filtered is retained within the kidney; 50% was recovered by enzymic assay and histologically localized to the

Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Serum levels, urinary excretion, and clearances of several proteins of different molecular weights were studied in 18 patients with mono- and myelomonocytic leukemia. Nine patients had normal renal function (group A) and nine had impaired renal function with azotemia (group B). The majority of

Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo

Markedly increased quantities of lysozyme have been found in the serum and urine (ranging to 2.6 g per day) of ten consecutive cases of monocytic and monomyelocytic leukemia. The enzyme has been isolated from the urine of several cases and physicochemically and immunochemically characterized. It is

Herbal & Natural Medicine

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

Travay nan 55 lang
Geri èrbal te apiye nan syans
Remèd fèy rekonesans pa imaj
Kat entèaktif GPS - tag zèb sou kote (vini byento)
Li piblikasyon syantifik ki gen rapò ak rechèch ou an
Search remèd fèy medsin pa efè yo
Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

muramidase/leukemia

Effect of human lysozyme (muramidase) on potassium handling by the perfused rat kidney. A mechanism for renal damage in human monocytic leukaemia.

Serum and urinary proteins, lysozyme (muramidase), and renal dysfunction in mono- and myelomonocytic leukemia.

Serum and urinary lysozyme (muramidase) in monocytic and monomyelocytic leukemia.

Muramidase in leukaemia.

Studies of muramidase in haematological disorders: serum and marrow muramidase in leukaemia.

Muramidase levels in leukemia.

[Studies on muramidase in leukemia].

[Chronic neutrophilic leukemia. Blood muramidase].

Studies on muramidase in hematologic disorders. I. Serum muramidase and serum lactic dehydrogenase in leukemia.

Serum muramidase levels in acute leukemia.

Letter: Urinary muramidase in hairy-cell leukemia.

[Serum muramidase activity in chronic myeloid leukemia].

Muramidase activity in leukemia and myeloproliferative disorders.

Muramidase in myeloproliferative disorders terminating in acute leukemia.

[Serum and urine muramidase activity in acute and chronic leukemia].

Baz done ki pi konplè remèd fèy medsin te apiye nan syans